Çocukluk Çağı Hashimoto Tiroiditi Tanılı Olguların Klinik Özellikleri ve İzlem Bulguları-Retrospektif Tek Merkez Deneyimi

Year 2019, Volume: 11 Issue: 1, 89 - 94, 25.03.2019

Özlem Korkmaz , Samim Özen , Damla Gökşen Şükran Darcan

https://doi.org/10.18521/ktd.432200

Cited By: 1

Abstract

Amaç: Çocuk ve ergenlerde Hashimoto tiroditi tanılı olguların başvuru ve izlem klinik ve laboratuvar özelliklerinin belirlenmesidir.

Gereç- Yöntem: Kliniğimizde Hashimoto Tiroiditi tanısıyla izlenen 83 olgunun başvuru izlemlerindeki klinik özellikleri, tiroid fonksiyon testleri, tiroid otoantikorları, ilaç tedavileri retrospektif olarak değerlendirildi.

Bulgular: Tanı anında ortalama yaş 11.3 ± 3.0 yaş olarak saptandı. Olguların %51.8’nin ailesinde tiroid hastalığı öyküsü alındı. Kız erkek oranı: 3.3/1 idi. Çalışma grubunun ağırlık standart deviasyon skoru (SDS) : 0.3 ± 1.3, boy SDS: 0.3 ± 2.8 olarak bulundu. Olguların %34.9’u rastlantısal, %27.7’si de guatr yakınması ile başvurdu. Fizik bakıda %68.7 oranında guatr saptandı. Tiroid fonksiyon testlerine göre başvuru sırasında ötiroidi %46.8, subklinik hipotiroidi %33.7, hipotiroidi %17.7, aşikar hipertiroidi %2.5, subklinik hipertiroidi %2.5 oranında bulundu. L-tiroksin tedavisi başlanılan grubun anti-TPO ve anti-Tg antikor düzeyleri tedavi başlanmayan olgulara kıyasla daha yüksek saptandı (p=0.01,p=0.051). Başlangıçta ötiroid olup ilaç başlanmayan 37 hastanın 13’üne (%35.1) izlemde sub-klinik ya da açık hipotiroidi geliştiği için L-tiroksin başlandı.

Sonuç: Hashimato Tiroiditi tanısıyla izlenen çocukluk çağı olguları başlangıçta ötiroid olsalar bile izlemde önemli bir kısmında hipotiroidi gelişebileceğinden düzenli aralıklarla tiroid fonksiyon testleri ile izlenmelidir.

Keywords

hashimoto tiroiditi, guatr, çocuk

Clinical Charecteristics and Follow- up Findings of the Cases Pediatric Hashimoto’ Thyroiditis- Retrospective a Single Centre Experience

Abstract

Objective:
The aim of this study was to evaluate the clinical and laboratory
characteristics at presentation  and
follow-up period of patients with Hashimoto  thyroiditis in children and adolescents.

Methods:
The clinical features, thyroid function tests, thyroid autoantibodies, tyhroid
ultrasound data and drug treatments of 83 patients with Hashimoto  thyroiditis at diagnosis and follow-up period
were retrospectively evaluated.

Results:
The mean age of the patients at the time of diagnosis was 11.3 ± 3.0 years .
The male to female ratio was 3.3 / 1. 51.8% of patients had a family history of
thyroid disease. The complaint at the time of presentation was goiter in 27.7 %
of the patients and 34.9% of the cases were coincidental determination. At
physical examination, 68.7% of goiter of the patients were found. According to
the thyroid function tests, 46.8% of the patients had euthyroidism, 33.7% of
subclinical hypothyroidism, 17.7% of hypothyroidism, 2.5% of hyperthyroidism
and 2.5% of subclinical hyperthyroidism. Anti-TPO and anti-Tg antibody levels
of the group in which L-thyroxine treatment was started were found to be higher
than those in the untreated patients (p = 0.01 and p = 0.051, respectively).
L-thyroxine was initiated in 13 (35.1%) of the 37 patients who were initially
euthyroid and did not receiving treatment at presentation because of
subclinical or clear hypothyroidism was observed of the follow-up.

Conclusion:
Thyroid functions of the pediatric patients with Hashimoto  thyroiditis should be follow up regular
intervals, even if they are initially euthyroid, since hypothyroidism may
develop in a significant cases of the follow-up period.

Keywords

hashimoto thyroiditis, goiter, child

References

• Referans1.Wasniewska M, Vigone MC, Cappa M, et al. Study Group for Thyroid diseases of Italian Society for Pediatric Endocrinology: Acute suppurative thyroiditis in childhood: relative frequency among thyroid inflammatory diseases. J Endocrinol Invest 2007;30(4):346–7.
• Referans2. Radetti G: Clinical aspects of Hashimoto’s thyroiditis. Endocr Dev 2014;26:158–70.
• Referans3.Radetti G, Gottardi E, Bona G, et al. The natural history of euthyroid Hashimoto's thyroiditis in children. J Pediatr 2006;149(6): 827-32.
• Referans4. Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's thyroiditis. Pediatr Endocrinol Rev 2003;1: 205-11.
• Referans5. Lazar L, Frumkin RB, Battat E, Lebenthal Y, Phillip M & Meyerovitch J. Natural history of thyroid function tests over 5 years in a large pediatric cohort. Journal of Clinical Endocrinology and Metabolism 2009;94:1678–82.
• Referans6. Zadik Z. Overuse or misuse of thyroid function tests in pediatrics. Journal of Pediatric Endocrinology & Metabolism 2009;22(10): 875–6.
• Referans7. Amino N, Tada H, Hidaka Y. Chronic (Hashimoto's) thyroiditis. In: DeGroot LJ, Jameson JL (eds). Endocrinology. 4th ed. Philadelphia, PA: WB Saunders;2001.p.1471– 80.
• Referans8. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty year followup of the Whickham survey. Clin Endocrinol 1995;43(1):55–68.
• Referans9. Gordin A, Lamberg BA. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: a long-term followup study. Clin Endocrinol 1981;15(6):537–43.
• Referans10. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291–303.
• Referans11. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006;95(2):194-8.
• Referans12. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years.Acta Paediatr 2006;95(12):1635-41.
• Referans13. Delange F, Benker G, Caron P, et al. Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. Eur J Endocrinol. 1997;136(2):180–7.
• Referans14. WHO. Recommended normative values for thyroid volume in children aged 6-15 years. World Health Organization & International Council for Control of Iodine Deficiency Disorders. Bull World Health Organ. 1997;75:95–7.
• Referans15. Gopalakrishnan S, Chugh PK, Chhillar M, Ambardar VK, Sahoo M, Sankar R. Goitrous autoimmune thyroiditis in a pediatric population: a longitudinal study. Pediatrics. 2008;122(3):670–74.
• Referans16. Desai MP, Karandikar S. Autoimmune thyroid disease in childhood: a study of children and their families. Indian Pediatr.1999;36(7):659–68.
• Referans17. Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikaşifoğlu A, Yordam N. Hashimoto’s thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease. J Pediatr Endocrinol Metab 2007;20(11):199-205.
• Referans18. Dilek E, İşcan B, Ekuklu G, Tütüncüler F. Hashimoto tiroiditi tanısı alan vakaların geriye dönük değerlendirilmesi.Çocuk Dergisi 2011;11(2):73-7.
• Referans19. Setian NS. Hypothyroidism in children: diagnosis and treatment. J Pediatr 2007; 83(5):209-16.
• Referans20. Marković S, Kostić G, Igrutinović Z, Vuletić B. Hashimoto's thyroiditis in children and adolescents. Srp Arh Celok Lek 2008; 136(5-6): 262-6.
• Referans21. Yeşilkaya E, Belen B, Bideci A, Çamurdan O, Boyraz M, Cinaz P. Kronik otoimmün tiroiditli çocuk ve ergenlerin klinik özellikleri. Gülhane Tıp Dergisi 2008; 50: 147-50.
• Referans22. Cappa M, Bizzarri C, Crea F. Autoimmune thyroid diseases in children. J Thyroid Res, 2011;675-703.
• Referans23. Caturegli P; De Remigis A; Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 2014;13(4-5): 391-7.
• Referans24. Giorgio Radetti. Clinical Aspects of Hashimoto’s Thyroiditis. Paediatric Thyroidology. Endocr Dev. Basel 2014; 26:158–70.
• Referans25. Romaldini JH, Biancalana MM, Figueiredo DI, Farah CS, Mathias PC. Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis. Thyroid 1996;6(3):183–8.
• Referans26. Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, Lindberg B, Ivarsson SA. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 2006;91(5):1729–34.
• Referans27. Vanderpump MP, French JM, Appleton D, Tunbridge WM, Kendall-Taylor P. The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort. Clin Endocrinol (Oxf) 1998;48(1):39–44.
• Referans28. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997;26(1):189–218.
• Referans29. Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002;12(10):839–47.
• Referans30. Wasniewska M, Corrias A, Salerno M, et al. Thyroid Function Patterns at Hashimoto's Thyroiditis Presentation in Childhood and Adolescence Are Mainly Conditioned by Patients' Age. Horm Res Paediatr 2012;78(4):232–236.
• Referans31. Sklar CA, Qazi R, David R. Juvenile autoimmune thyroiditis. Am J Dis Child 1986;140(9):877– 880.
• Referans32. Wasniewska M, Corrias A, Salerno M, et al. Outcomes of children with hashitoxicosis. Horm Res Paediatr. 2012;77(1):36–40.
• Referans33. Yoshida H, Amino N, Yagawa K, et al. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab 1978;46(6):859–62.
• Referans34. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab. 1990;71(3):661–9.
• Referans35. Padberg S, Heller K, Usadel KH, Schumm-Draeger PM. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit? Thyroid. 2001;11(3):249–55.